Let-7a-3 Promoter Hypomethylation Induces Apoptosis of Trophoblast Cells in Early-Onset Severe Preeclampsia by Targeting Bcl-xl and YAP1

Wenhui Zha,Shuang Guan,Ning Liu,Yang Li,Yuan Tian,Yang Chen,Yan Wang,Fuju Wu

DOI: https://doi.org/10.2139/ssrn.3444402

2019-01-01

Abstract:Background: Dysregulation of the Let-7 family has been implicated in preeclampsia (PE). Abnormal trophoblast cell proliferation and apoptosis associate with the pathogenesis of PE. The present study was designed to test the hypothesis whether let-7a-5p could regulate the biological functions of trophoblasts and explore the mechanism how it works in the development of early-onset severe PE. Methods: The putative target genes Bcl-xl and YAP1 of let-7a-5p were verified by luciferase assay. The roles of let-7a-5p, Bcl-xl and YAP1 in regulating JEG-3 cell functions were examined by altering their expression with mimic, overexpression plasmids or siRNAs. The methylation status of let-7a-3 in PE was assessed by methylation-specific and bisulfite sequencing PCR assays. JEG-3 cells were treated with DNA methyltransferase inhibitor to analyze whether let-7a-3 demethylation functioned in PE. Tumor growth and cell apoptosis were measured from nude mice inoculated with JEG-3 cells overexpressing let-7a-5p. Results: The results revealed let-7a-5p was highly expressed in early-onset severe PE with a low methylation level. Functionally, let-7a-5p upregulation could inhibit the viability and cell cycle progression but induce the apoptosis of JEG-3 cells. Bcl-xl and YAP1, target genes of let-7a-5p, could rescue cell apoptosis induced by let-7a-5p. The demethylation of let-7a-3 was also observed to enhance JEG-3 cell apoptosis. Let-7a-5p inhibited tumorigenic ability of JEG-3 cells and enhanced cell apoptosis in vivo. Conclusions: Altogether, let-7a-5p could exert an anti-proliferative role in trophoblasts through downregulation of Bcl-xl and YAP1, which suggests that let-7a-3 might be a key regulator in the progression of PE.Funding Statement: This study was supported by the Department of Science and Technology of Jilin Province (20170204045SF).Declaration of Interests: The authors declare that they have no conflict of interest.Ethics Approval Statement: The study performed with the approval of the Ethics Committee and Animal Ethics Committee of the Second Hospital of Jilin University. All participants signed informed consent documentation prior to being enrolled. All animal experimentation was performed in strict compliance with the National Institute of Health’s Guidelines for Laboratory Animal Care and Use in Biomedical Research.